Position in BMY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$74,560
-$3,921 QoQ
Shares Held
1,294
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,278
of 2,506 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Security National Bank holds $9,534,118 across 10 Drug Manufacturers - General names. BMY ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,085 | $3,831,137 | |
| 2 | LLY |
ELI LILLY & Co
|
2,326 | $2,789,874 | |
| 3 | AZN |
Astrazeneca PLC
|
8,964 | $1,699,753 | |
| 4 | AMGN |
Amgen Inc
|
1,713 | $620,311 | |
| 5 | ABBV |
AbbVie Inc.
|
1,182 | $297,437 | |
| 6 | GSK |
GSK plc
|
2,359 | $123,658 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
1,294 | $74,560 | |
| 8 | PFE |
Pfizer Inc
|
2,522 | $60,729 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,560 | 1,294 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $78,481 | 1,294 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $69,798 | 1,294 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $58,359 | 1,294 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $59,899 | 1,294 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $73,614 | 1,207 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $68,267 | 1,207 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||